Great Basin Scientific (Great Basin Scientific) Debt-to-Revenue : 10.02 (As of Mar. 2017)

View and export this data going back to 2014. Start your Free Trial

What is Great Basin Scientific Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Great Basin Scientific's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2017 was $33.25 Mil. Great Basin Scientific's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2017 was $0.05 Mil. Great Basin Scientific's annualized Revenue for the quarter that ended in Mar. 2017 was $3.32 Mil. Great Basin Scientific's annualized Debt-to-Revenue for the quarter that ended in Mar. 2017 was 10.02.

Great Basin Scientific Debt-to-Revenue Historical Data

The historical data trend for Great Basin Scientific's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Great Basin Scientific Debt-to-Revenue Chart

Great Basin Scientific Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Debt-to-Revenue

4.00

3.48

1.97

10.00

25.07

Great Basin Scientific Quarterly Data
	Dec12	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Debt-to-Revenue	Get a 7-Day Free Trial												3.64	5.52	9.81	22.42	10.02

Competitive Comparison of Great Basin Scientific's Debt-to-Revenue

For the Diagnostics & Research subindustry, Great Basin Scientific's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Great Basin Scientific's Debt-to-Revenue Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Great Basin Scientific's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Great Basin Scientific's Debt-to-Revenue falls into.

Great Basin Scientific Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Great Basin Scientific's Debt-to-Revenue for the fiscal year that ended in Dec. 2016 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(61.365	+	15.056)	/	3.048
	=	25.07

Great Basin Scientific's annualized Debt-to-Revenue for the quarter that ended in Mar. 2017 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(33.246	+	0.052)	/	3.324
	=	10.02

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is four times the quarterly (Mar. 2017) Revenue data.

Great Basin Scientific Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Great Basin Scientific's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Great Basin Scientific (Great Basin Scientific) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Great Basin Scientific Inc (GREY:GBSNQ) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

N/A

Address

420 East South Temple, Suite 520, Salt Lake City, UT, USA, 84111

Website

http://www.gbscience.com

Great Basin Scientific Inc is the United States based molecular diagnostic testing company. It is focused on the development and commercialization of molecular diagnostic platform designed to test for the infectious disease, especially hospital-acquired infections. Molecular diagnostic testing reduces test time from days to hours compared to culture methods. The company's system includes an analyzer, which it provides for the customers' use without charge in the United States, and a diagnostic cartridge, which it sells to the customers. The group derives its revenue from the sale of single-use assays sold in the United States, the European Union, and New Zealand, of which majority of the revenue is generated from the United States.

Great Basin Scientific (Great Basin Scientific) Headlines

No Headlines